SPOTLIGHT -
Expert panelists share experiences and best practices from a payer perspective regarding the use of bispecifics in patients with multiple myeloma.
EP. 1: COMING SOON: Bispecifics in Multiple Myeloma: Payer Perspectives
Cesar R. Valdes, MD, shares his excitement for an upcoming program centered on payer perspective regarding the use of bispecifics in patients with multiple myeloma.